Hefty Action in a Pair of Biotechs
Some of the Nasdaq's biggest upside movers Monday in heavier-than-normal trading volume hailed from the biotech area of healthcare.
As I've often written here, it's worth tracking such stocks in a poor market, as they could be setting up for more price gains when a new uptrend is defined. Generally I run scans for companies that are showing double-digit earnings growth, driven by rising revenue....505 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.
There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.
Already a Subscriber? Please login.
